Uganda launches HPV vaccine program; Two in U.K. prove rogue MMR strain rendered them deaf;

> In Uganda, a nationwide program has been launched to vaccinate girls against human papillomavirus (HPV), the precursor to cervical cancer. News

> A study examining HIV vaccine research over the past 5 years shows that Canada ranks first per capita in the number of articles published, compared with other leading nations taking part in research, like the U.S. Overall, Canada ranked fourth in the number of scholarly articles published on the topic. Article

> Two individuals in the U.K. proved to the country's Vaccine Damage Payments Unit that a rogue strain of the MMR vaccine left them deaf after receiving it between 1988 and 1992. Story

> With reports of the West Nile virus across 48 states and no vaccine in the foreseeable future, scientists from the University of Alabama at Birmingham urge individuals to be diligent in using mosquito repellant. Release

> Abbott ($ABT) and Astellas Pharma announced that they will collaborate on a Phase III clinical trial to test ASP0113, a candidate vaccine to prevent cytomegalovirus from occurring in organ transplant recipients. Release

Suggested Articles

Novavax will have billions of doses of COVID-19 vaccine capacity next year and could single-handedly meet U.S. demand, executives said.

As top players race to deliver COVID-19 vaccines, Russia approved a locally developed shot based on skimpy data. Experts called it a political stunt.

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan